LLMpediaThe first transparent, open encyclopedia generated by LLMs

AP3

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 57 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted57
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
AP3
NameAP3
OrganismHomo sapiens
LocationGolgi apparatus, Endosome
Functionprotein trafficking, vesicle formation

AP3

AP3 is a multisubunit adaptor complex involved in intracellular vesicular transport and cargo sorting. First characterized through biochemical fractionation and genetic screens, AP3 participates in the formation of transport vesicles at the Golgi apparatus and endosomes and directs cargo to lysosome-related organelles such as melanosomes and platelet dense granules. Mutations affecting AP3 subunits have been implicated in human syndromes and in model-organism phenotypes studied in Drosophila melanogaster, Mus musculus, and Saccharomyces cerevisiae.

Etymology and Nomenclature

The designation "AP3" derives from early biochemical classification of adaptor protein complexes where AP1, AP2, AP3, and AP4 were named sequentially following work in laboratories researching clathrin-coated vesicles and adaptor complexes at institutions such as the Medical Research Council and the Max Planck Society. Subunit nomenclature uses Greek letters (beta, mu, sigma, delta, etc.) and gene symbols standardized by the HUGO Gene Nomenclature Committee and the International Union of Biochemistry and Molecular Biology. Historical literature cites foundational contributions from researchers at the National Institutes of Health and the European Molecular Biology Laboratory who connected genetic phenotypes in Drosophila and clinical observations in Hermansky–Pudlak syndrome cohorts to loss of AP3 function.

Gene and Protein Structure

AP3 exists as a heterotetrameric complex composed of large, medium, and small subunits encoded by distinct genes conserved across eukaryotes, including orthologs in Caenorhabditis elegans, Arabidopsis thaliana, and Danio rerio. The large subunit (often annotated as beta or delta) contains appendage domains homologous to those in the AP1 and AP2 families, as described in structural studies from groups at University of Oxford and Harvard Medical School. The medium subunit (mu) harbors a cargo-recognition pocket that binds tyrosine-based motifs identified in membrane proteins characterized by investigators at Stanford University and the Scripps Research Institute. Crystal structures and cryo-electron microscopy reconstructions from teams affiliated with the European Synchrotron Radiation Facility revealed conserved helical solenoids and adaptor appendage folds shared with clathrin adaptors. Gene families include paralogs and isoforms with tissue-specific expression noted in datasets from the Human Protein Atlas and transcriptome analyses performed at the Broad Institute.

Biological Function and Mechanism

AP3 mediates selective sorting of transmembrane cargo into budding vesicles at the trans-Golgi network and endosomal membranes, working in pathways that intersect with Rab GTPase-regulated trafficking and with coat proteins studied in experiments at the Max Planck Institute of Molecular Cell Biology and Genetics. AP3 recognizes dileucine- and tyrosine-based sorting signals on cargo proteins, cooperating with accessory factors such as VAMP family v-SNAREs, BLOC complexes, and tethering factors described by researchers at the Yale School of Medicine and the University of Cambridge. Functional assays in cell lines from the American Type Culture Collection demonstrated AP3-dependent trafficking to melanosomes, platelet dense granules, and synaptic vesicles in neurons analyzed at centers including the Salk Institute for Biological Studies. Mechanistically, AP3 promotes membrane curvature and coat assembly, coordinating with motors such as dynein and kinesin for vesicle movement along microtubules as shown in live-imaging studies at the European Molecular Biology Laboratory.

Clinical Significance and Associated Disorders

Loss-of-function variants in AP3 subunit genes cause syndromic disorders affecting pigmentation, bleeding, and immune responses, with clinical descriptions appearing in case series from the Mayo Clinic and translational reports from the Children's Hospital of Philadelphia. Mutations are classically associated with forms of Hermansky–Pudlak syndrome and with inherited platelet storage pool deficiencies documented by hematology groups at the Johns Hopkins Hospital. Neurological phenotypes, including seizures and developmental delay, have been reported in cohorts studied at the Karolinska Institutet and in genetic screens from the Deciphering Developmental Disorders project. AP3 dysfunction also influences pathogen susceptibility, altering intracellular trafficking of receptors and effectors in studies of Mycobacterium tuberculosis and Salmonella infection performed at the Wellcome Sanger Institute and the Rockefeller University.

Research Techniques and Model Systems

Investigation of AP3 leverages genetics, biochemistry, and imaging in diverse model systems. Classical mutants in Drosophila melanogaster (ap3-related alleles) and knockout mice from groups at the Jackson Laboratory elucidated roles in pigmentation and platelet biology. Cell biological approaches include co-immunoprecipitation, proximity labeling, and mass spectrometry pipelines developed at the Proteomics Facility, EMBL to map AP3 interactomes with cargo such as LAMP1, TYRP1, and SLC35A2. Structural studies employ cryo-EM at facilities like the National Center for Electron Microscopy and X-ray crystallography at synchrotrons such as the Diamond Light Source. Live-cell total internal reflection fluorescence microscopy and super-resolution imaging by labs at the Max Planck Institute for Biophysical Chemistry have visualized AP3-dependent budding events, while genome-editing with CRISPR-Cas9 in human induced pluripotent stem cells generated by teams at MIT permit modeling patient-specific variants for translational research.

Category:Protein complexes